ŠIMKOVÁ, Vladislava, Peter RADERMACHER a Eberhard BARTH. Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use? Critical Care. London: BioMed Central Ltd, 2007, roč. 11, č. 3, s. 139. ISSN 1364-8535. |
Další formáty:
BibTeX
LaTeX
RIS
@article{750372, author = {Šimková, Vladislava and Radermacher, Peter and Barth, Eberhard}, article_location = {London}, article_number = {3}, keywords = {inhibitory fosfodiesterázy III}, language = {eng}, issn = {1364-8535}, journal = {Critical Care}, title = {Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use?}, url = {http://ccforum.com}, volume = {11}, year = {2007} }
TY - JOUR ID - 750372 AU - Šimková, Vladislava - Radermacher, Peter - Barth, Eberhard PY - 2007 TI - Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use? JF - Critical Care VL - 11 IS - 3 SP - 139 EP - 139 PB - BioMed Central Ltd SN - 13648535 KW - inhibitory fosfodiesterázy III UR - http://ccforum.com N2 - Phosphodiesterase III inhibitors combine positive inotropic and vasodilator properties. These inhibitors are therefore frequently used to treat low cardiac output and/or severe left heart failure associated with cardiac surgery. Their effects on energy metabolism and visceral organ function are not well studied, however, particularly in comparison with their 'competitors' in daily practice (that is, catecholamines). ER -
ŠIMKOVÁ, Vladislava, Peter RADERMACHER a Eberhard BARTH. Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use? \textit{Critical Care}. London: BioMed Central Ltd, 2007, roč.~11, č.~3, s.~139. ISSN~1364-8535.
|